Hepatitis B cure: modeling the economics of a potential cost of a cure.

摘要: PURPOSE OF REVIEW The cure for hepatitis C virus infection has raised hope a potential B (HBV) cure, but the high price tag led to serious questions about affordability, and thus access all. This review discusses cost-effectiveness models, new chronic HBV infection. RECENT FINDINGS A does not yet exist HBV, antiviral treatments that are currently available help slow down progression of disease. There is limited research in area economic analysis comparing cure. Our preliminary findings from modeling threshold show could be potentially cost-effective or cost-saving. Governments can possibly use results models negotiations. SUMMARY highest burden low middle-income countries. Given cost current treatment dropped dramatically recent years as first line have come off patent, needs reasonable affordable all people.